91 related articles for article (PubMed ID: 27509031)
1. Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.
Das L; Anderson TA; Gard JM; Sroka IC; Strautman SR; Nagle RB; Morrissey C; Knudsen BS; Cress AE
J Cell Biochem; 2017 May; 118(5):1038-1049. PubMed ID: 27509031
[TBL] [Abstract][Full Text] [Related]
2. Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites.
Schmelz M; Cress AE; Scott KM; Bürger F; Cui H; Sallam K; McDaniel KM; Dalkin BL; Nagle RB
Neoplasia; 2002; 4(3):243-54. PubMed ID: 11988844
[TBL] [Abstract][Full Text] [Related]
3. Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo.
Marr KD; Gard JMC; Harryman WL; Keeswood EJ; Paxson AI; Wolgemuth C; Knudsen BS; Nagle RB; Hazlehurst L; Sorbellini M; Cress AE
Biophys J; 2023 Nov; 122(21):4194-4206. PubMed ID: 37766428
[TBL] [Abstract][Full Text] [Related]
4. Ligand-Occupied Integrin Internalization Links Nutrient Signaling to Invasive Migration.
Rainero E; Howe JD; Caswell PT; Jamieson NB; Anderson K; Critchley DR; Machesky L; Norman JC
Cell Rep; 2015 Jan; 10(3):398-413. PubMed ID: 25600874
[TBL] [Abstract][Full Text] [Related]
5. The Cohesive Metastasis Phenotype in Human Prostate Cancer.
Harryman WL; Hinton JP; Rubenstein CP; Singh P; Nagle RB; Parker SJ; Knudsen BS; Cress AE
Biochim Biophys Acta; 2016 Dec; 1866(2):221-231. PubMed ID: 27678419
[TBL] [Abstract][Full Text] [Related]
6. The roles of integrin αvβ6 in cancer.
Niu J; Li Z
Cancer Lett; 2017 Sep; 403():128-137. PubMed ID: 28634043
[TBL] [Abstract][Full Text] [Related]
7. Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c.
Wan Q; Zeng Z; Qi J; Zhao Y; Liu X; Chen Z; Zhou H; Zu Y
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326720
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism.
Siech C; Rutz J; Maxeiner S; Grein T; Sonnenburg M; Tsaur I; Chun FK; Blaheta RA
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053528
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the Molecular Machinery-Influence of sE-Cadherin on Tumorigenic Traits of Prostate Cancer Cells.
Tsaur I; Thomas A; Juengel E; Maxeiner S; Grein T; Le QC; Muschta V; Rutz J; Chun FKH; Blaheta RA
Biology (Basel); 2021 Oct; 10(10):. PubMed ID: 34681106
[TBL] [Abstract][Full Text] [Related]
10. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field.
Ludwig BS; Kessler H; Kossatz S; Reuning U
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916607
[TBL] [Abstract][Full Text] [Related]
11. Targeted Drug Delivery via the Use of ECM-Mimetic Materials.
Hwang J; Sullivan MO; Kiick KL
Front Bioeng Biotechnol; 2020; 8():69. PubMed ID: 32133350
[TBL] [Abstract][Full Text] [Related]
12. Integrin α5/ITGA5 Promotes The Proliferation, Migration, Invasion And Progression Of Oral Squamous Carcinoma By Epithelial-Mesenchymal Transition.
Deng Y; Wan Q; Yan W
Cancer Manag Res; 2019; 11():9609-9620. PubMed ID: 32009816
[TBL] [Abstract][Full Text] [Related]
13. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.
Arias-Pinilla GA; Dalgleish AG; Mudan S; Bagwan I; Walker AJ; Modjtahedi H
Sci Rep; 2020 Jan; 10(1):537. PubMed ID: 31953437
[TBL] [Abstract][Full Text] [Related]
14. ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival.
Van Duzer A; Taniguchi S; Elhance A; Tsujikawa T; Oshimori N
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31792062
[TBL] [Abstract][Full Text] [Related]
15. A Method to Reuse Archived H&E Stained Histology Slides for a Multiplex Protein Biomarker Analysis.
Hinton JP; Dvorak K; Roberts E; French WJ; Grubbs JC; Cress AE; Tiwari HA; Nagle RB
Methods Protoc; 2019 Nov; 2(4):. PubMed ID: 31731599
[TBL] [Abstract][Full Text] [Related]
16. Integrin α6β4E variant is associated with actin and CD9 structures and modifies the biophysical properties of cell-cell and cell-extracellular matrix interactions.
Wang M; Hinton JP; Gard JMC; Garcia JGN; Knudsen BS; Nagle RB; Cress AE
Mol Biol Cell; 2019 Mar; 30(7):838-850. PubMed ID: 30865564
[TBL] [Abstract][Full Text] [Related]
17. Integrin α-3 ß-1's central role in breast cancer, melanoma and glioblastoma cell aggregation revealed by antibodies with blocking activity.
Lusche DF; Klemme MR; Soll BA; Reis RJ; Forrest CC; Nop TS; Wessels DJ; Berger B; Glover R; Soll DR
MAbs; 2019; 11(4):691-708. PubMed ID: 30810437
[TBL] [Abstract][Full Text] [Related]
18. Integrin trafficking in cells and tissues.
Moreno-Layseca P; Icha J; Hamidi H; Ivaska J
Nat Cell Biol; 2019 Feb; 21(2):122-132. PubMed ID: 30602723
[TBL] [Abstract][Full Text] [Related]
19. HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression.
Makarević J; Rutz J; Juengel E; Maxeiner S; Mani J; Vallo S; Tsaur I; Roos F; Chun FK; Blaheta RA
Cells; 2018 Sep; 7(9):. PubMed ID: 30200497
[TBL] [Abstract][Full Text] [Related]
20. Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.
Das L; Gard JMC; Prekeris R; Nagle RB; Morrissey C; Knudsen BS; Miranti CK; Cress AE
Mol Cancer Res; 2018 Aug; 16(8):1319-1331. PubMed ID: 29759989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
